Experimental data on the involvement of the blood anticoagulant system components (heparin complex compounds, short regulatory peptides) in fibrin formation processes are presented. Inhibition of thrombin activity and interactions of short glyproline peptides and their heparin complexes with fibrin monomer molecules are demonstrated. Peptides and their heparin complexes prevent the formation of primary polymeric fibrin and exhibit fibrin-depolymerizing activity on the formed polymeric fibrin. The mechanisms underlying the effects of heparin complexes on degradation of fibrin not stabilized with factor XIIIa is discussed on the basis of the results of spectral analysis and coagulation tests.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ashmarin IP, Karazeeva EP, Lyapina LA, Samonina GE. The simplest proline-containing peptides PG, GP, PGP, and GPGG: regulatory activity and possible sources of biosynthesis. Biochemistry (Mosc.). 1998;63(2):119-124.
Lugovskoi EV, Makogonenko EM, Komisarenko SV. Molecular Mechanisms of Fibrin Formation and Destruction: Physicochemical and Immunochemical Analysis. Kiev, 2013. Russian.
Lyapina LA, Grigor’eva ME, Obergan TYu, Shubina TA. Theoretical and Practical Issues of Studying Functional State of the Blood Anticoagulant System. Moscow, 2012. Russian.
Myasoedov NF, Andreeva LA, Lyapina LA, Ulyanov AM, Shubina TA, Obergan TY, Pastorova VE, Grigorieva ME. The combined antidiabetogenic and anticoagulation effect of tripeptide Gly-Pro-Arg as estimated in the model of persistent hyperglycemia in rats. Doklady Biol. Sci. 2011;438(1):135-137.
Obergan TY, Shubina TA, Grigorieva ME, Lyapina LA, Myasoedov NF, Andreeva LA, Pastorova VE. Participation of the peptide Pro-Gly-Pro-Leu in restoration of functions anticoagulant and insular organism systems at development by a proof hyperglycemia at rats. Vopr. Biol. Med. Farm. Khimii. 2013;11(4):38-42. Russian.
Kudrjashov BA, Lyapina LA. Nonenzymatic fibrinolysis and its role in the organism. Thrombosis and thrombolysis. Chazov EI, Smirnov VN, eds. New York, 1986. P. 365-389.
Kudrjashov BA, Uljanov AM, Shitnikova ES. Electronmicroscopic study on the molecular shape of non-stabilized fibrin break-down products produced by complex heparin compounds. Folia Haematol. Int. Mag Klin. Morphol. Blutforsch. 1980;107(6):895-905.
Myasoedov NF, Lyapina LA, Grigorjeva ME, Obergan TY, Shubina TA, Andreeva LA. Mechanisms for glyproline protection in hypercholesterolemia. Pathophysiology. 2016;23(1):27-33.
Shabalina AA, Liapina LA, Rochev DL, Kostyreva MV, Tanashian MM, Suslina ZA. In vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood. Izv. Akad. Nauk. Ser. Biol. 2015;(1):85-89.
Schwartz L. Heparin comes clean. N. Engl. J. Med. 2008; 358(23):2505-2509.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 1, pp. 56-59, January, 2017
Rights and permissions
About this article
Cite this article
Lyapina, L.A., Maistrenko, E.S. Regulation of Primary Polymerization of Fibrin by Blood Anticoagulant System Components. Bull Exp Biol Med 163, 46–48 (2017). https://doi.org/10.1007/s10517-017-3734-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3734-x